• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌的全基因组重建与突变特征

Whole-genome reconstruction and mutational signatures in gastric cancer.

作者信息

Nagarajan Niranjan, Bertrand Denis, Hillmer Axel M, Zang Zhi Jiang, Yao Fei, Jacques Pierre-Étienne, Teo Audrey S M, Cutcutache Ioana, Zhang Zhenshui, Lee Wah Heng, Sia Yee Yen, Gao Song, Ariyaratne Pramila N, Ho Andrea, Woo Xing Yi, Veeravali Lavanya, Ong Choon Kiat, Deng Niantao, Desai Kartiki V, Khor Chiea Chuen, Hibberd Martin L, Shahab Atif, Rao Jaideepraj, Wu Mengchu, Teh Ming, Zhu Feng, Chin Sze Yung, Pang Brendan, So Jimmy B Y, Bourque Guillaume, Soong Richie, Sung Wing-Kin, Tean Teh Bin, Rozen Steven, Ruan Xiaoan, Yeoh Khay Guan, Tan Patrick B O, Ruan Yijun

出版信息

Genome Biol. 2012 Dec 13;13(12):R115. doi: 10.1186/gb-2012-13-12-r115.

DOI:10.1186/gb-2012-13-12-r115
PMID:23237666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4056366/
Abstract

BACKGROUND

Gastric cancer is the second highest cause of global cancer mortality. To explore the complete repertoire of somatic alterations in gastric cancer, we combined massively parallel short read and DNA paired-end tag sequencing to present the first whole-genome analysis of two gastric adenocarcinomas, one with chromosomal instability and the other with microsatellite instability.

RESULTS

Integrative analysis and de novo assemblies revealed the architecture of a wild-type KRAS amplification, a common driver event in gastric cancer. We discovered three distinct mutational signatures in gastric cancer--against a genome-wide backdrop of oxidative and microsatellite instability-related mutational signatures, we identified the first exome-specific mutational signature. Further characterization of the impact of these signatures by combining sequencing data from 40 complete gastric cancer exomes and targeted screening of an additional 94 independent gastric tumors uncovered ACVR2A, RPL22 and LMAN1 as recurrently mutated genes in microsatellite instability-positive gastric cancer and PAPPA as a recurrently mutated gene in TP53 wild-type gastric cancer.

CONCLUSIONS

These results highlight how whole-genome cancer sequencing can uncover information relevant to tissue-specific carcinogenesis that would otherwise be missed from exome-sequencing data.

摘要

背景

胃癌是全球癌症死亡的第二大原因。为了探索胃癌体细胞改变的完整图谱,我们结合了大规模平行短读长测序和DNA双末端标签测序,对两例胃腺癌进行了首次全基因组分析,其中一例具有染色体不稳定性,另一例具有微卫星不稳定性。

结果

综合分析和从头组装揭示了野生型KRAS扩增的结构,这是胃癌中常见的驱动事件。我们在胃癌中发现了三种不同的突变特征——在全基因组氧化和微卫星不稳定性相关突变特征的背景下,我们鉴定出了首个外显子特异性突变特征。通过结合40例完整胃癌外显子组的测序数据,并对另外94例独立胃肿瘤进行靶向筛查,进一步表征这些特征的影响,发现ACVR2A、RPL22和LMAN1是微卫星不稳定性阳性胃癌中反复突变的基因,而PAPPA是TP53野生型胃癌中反复突变的基因。

结论

这些结果突出了全基因组癌症测序如何能够揭示与组织特异性致癌作用相关的信息,而这些信息在全外显子组测序数据中可能会被遗漏。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b3/4056366/3df488e38adf/gb-2012-13-12-r115-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b3/4056366/1815fe942d6a/gb-2012-13-12-r115-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b3/4056366/e4726b2c587e/gb-2012-13-12-r115-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b3/4056366/3df488e38adf/gb-2012-13-12-r115-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b3/4056366/1815fe942d6a/gb-2012-13-12-r115-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b3/4056366/e4726b2c587e/gb-2012-13-12-r115-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b3/4056366/3df488e38adf/gb-2012-13-12-r115-3.jpg

相似文献

1
Whole-genome reconstruction and mutational signatures in gastric cancer.胃癌的全基因组重建与突变特征
Genome Biol. 2012 Dec 13;13(12):R115. doi: 10.1186/gb-2012-13-12-r115.
2
The chronological sequence of somatic mutations in early gastric carcinogenesis inferred from multiregion sequencing of gastric adenomas.从胃腺瘤的多区域测序推断早期胃癌发生过程中体细胞突变的时间顺序。
Oncotarget. 2016 Jun 28;7(26):39758-39767. doi: 10.18632/oncotarget.9250.
3
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.胃腺癌外显子组测序鉴定细胞黏附与染色质重塑基因中的重现性体细胞突变。
Nat Genet. 2012 May;44(5):570-4. doi: 10.1038/ng.2246.
4
Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.通过全外显子组测序和靶向基因测序揭示的透明细胞子宫内膜肿瘤的体细胞突变谱。
Cancer. 2017 Sep 1;123(17):3261-3268. doi: 10.1002/cncr.30745. Epub 2017 May 9.
5
Mutational signatures in 175 Chinese gastric cancer patients.175 例中国胃癌患者的突变特征。
BMC Cancer. 2024 Sep 30;24(1):1208. doi: 10.1186/s12885-024-12968-2.
6
Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.胃癌的基因突变图谱和基于目标下一代测序的基因组分析的临床应用。
J Transl Med. 2019 Jun 4;17(1):189. doi: 10.1186/s12967-019-1941-0.
7
Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis.通过全外显子组下一代测序和生物信息学分析鉴定的 MSI 和 MSS 结直肠癌的体细胞突变谱。
PLoS One. 2010 Dec 22;5(12):e15661. doi: 10.1371/journal.pone.0015661.
8
Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.深度靶向测序及其对中国胃腺癌患者癌症治疗的潜在影响。
Oncologist. 2021 May;26(5):e756-e768. doi: 10.1002/onco.13695. Epub 2021 Feb 8.
9
The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers.早期胃癌的突变负担和进化年龄与晚期胃癌相当。
J Pathol. 2014 Nov;234(3):365-74. doi: 10.1002/path.4401. Epub 2014 Aug 11.
10
Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.幽门螺杆菌感染胃上皮细胞中 TP53 的体细胞突变积累。
Gastroenterology. 2014 Aug;147(2):407-17.e3. doi: 10.1053/j.gastro.2014.04.036. Epub 2014 Apr 29.

引用本文的文献

1
Targeting the BAG2/CHIP axis promotes gastric cancer apoptosis by blocking apoptosome assembly.靶向BAG2/CHIP轴通过阻断凋亡小体组装促进胃癌细胞凋亡。
Front Immunol. 2025 Jul 18;16:1578416. doi: 10.3389/fimmu.2025.1578416. eCollection 2025.
2
KRAS amplification in colorectal cancer: correlations with clinicopathological features and prognosis in patients and prediction of response to targeted therapy.结直肠癌中KRAS基因扩增:与患者临床病理特征及预后的相关性以及对靶向治疗反应的预测
J Transl Med. 2025 Jul 24;23(1):824. doi: 10.1186/s12967-025-06864-x.
3
The Central Role of Ribosomal Proteins in p53 Regulation.

本文引用的文献

1
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.胃腺癌外显子组测序鉴定细胞黏附与染色质重塑基因中的重现性体细胞突变。
Nat Genet. 2012 May;44(5):570-4. doi: 10.1038/ng.2246.
2
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.胃癌中基因组改变的全面调查揭示了不同治疗靶点之间分子排他性和共同发生的系统模式。
Gut. 2012 May;61(5):673-84. doi: 10.1136/gutjnl-2011-301839. Epub 2012 Feb 7.
3
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.
核糖体蛋白在p53调控中的核心作用。
Cancers (Basel). 2025 May 8;17(10):1597. doi: 10.3390/cancers17101597.
4
Ribosome specialization by cancer-associated ribosomal protein mutations: progress made and open questions.癌症相关核糖体蛋白突变导致的核糖体特化:取得的进展与待解决的问题
Philos Trans R Soc Lond B Biol Sci. 2025 Mar 6;380(1921):20230380. doi: 10.1098/rstb.2023.0380.
5
RNAi-based biocontrol for crops: a revised expectation for a non-recent technology.基于RNA干扰的作物生物防治:对一项非新兴技术的重新期望。
Planta. 2025 Jan 25;261(2):44. doi: 10.1007/s00425-025-04625-0.
6
Mutational signatures in 175 Chinese gastric cancer patients.175 例中国胃癌患者的突变特征。
BMC Cancer. 2024 Sep 30;24(1):1208. doi: 10.1186/s12885-024-12968-2.
7
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair.具有微卫星不稳定高和/或错配修复缺陷的胃癌的有效治疗策略。
Gastric Cancer. 2024 Sep;27(5):907-931. doi: 10.1007/s10120-024-01523-4. Epub 2024 Jun 26.
8
Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy.解码核糖体异质性:癌症治疗的新前沿。
Biomedicines. 2024 Jan 11;12(1):155. doi: 10.3390/biomedicines12010155.
9
DNMT1 expression partially dictates 5-Azacytidine sensitivity and correlates with RAS/MEK/ERK activity in gastric cancer cells.DNMT1 表达部分决定了 5-氮杂胞苷的敏感性,并与胃癌细胞中的 RAS/MEK/ERK 活性相关。
Epigenetics. 2023 Dec;18(1):2254976. doi: 10.1080/15592294.2023.2254976.
10
PITPNA-AS1/miR-98-5p to Mediate the Cisplatin Resistance of Gastric Cancer.PITPNA-AS1/miR-98-5p介导胃癌顺铂耐药性
J Oncol. 2022 May 7;2022:7981711. doi: 10.1155/2022/7981711. eCollection 2022.
外显子组测序鉴定出胃癌分子亚型中 ARID1A 的高频突变。
Nat Genet. 2011 Oct 30;43(12):1219-23. doi: 10.1038/ng.982.
4
Opera: reconstructing optimal genomic scaffolds with high-throughput paired-end sequences.Opera:利用高通量双末端序列重建最优基因组支架
J Comput Biol. 2011 Nov;18(11):1681-91. doi: 10.1089/cmb.2011.0170. Epub 2011 Sep 19.
5
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.全基因组测序鉴定慢性淋巴细胞白血病中的反复突变。
Nature. 2011 Jun 5;475(7354):101-5. doi: 10.1038/nature10113.
6
Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes.全面的长跨度配对末端标签映射揭示了上皮癌基因组中结构变异的特征模式。
Genome Res. 2011 May;21(5):665-75. doi: 10.1101/gr.113555.110. Epub 2011 Apr 5.
7
Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5.激活诱导的胞苷脱氨酶通过与Spt5相互作用,靶向RNA聚合酶II停滞位点的DNA。
Cell. 2010 Oct 1;143(1):122-33. doi: 10.1016/j.cell.2010.09.017.
8
Helicobacter pylori-induced activation-induced cytidine deaminase expression and carcinogenesis.幽门螺杆菌诱导的激活诱导胞苷脱氨酶表达与致癌作用。
Curr Opin Immunol. 2010 Aug;22(4):442-7. doi: 10.1016/j.coi.2010.06.001.
9
The mutation spectrum revealed by paired genome sequences from a lung cancer patient.配对肺癌患者基因组序列揭示的突变谱。
Nature. 2010 May 27;465(7297):473-7. doi: 10.1038/nature09004.
10
Risk factors in gastric cancer.胃癌的危险因素。
Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):302-8.